Real-time enrollment status for this heart failure with preserved ejection fraction (hfpef) clinical trial
Current Status
Recruiting
Checked: October 24, 2026 at 11:00 PM UTC
| NCT Number | NCT07761117 |
| Recruiting Status | Recruiting |
| Condition | Heart Failure With Preserved Ejection Fraction (HFpEF) |
| Phase | PHASE3 |
| Target Enrollment | 6,950 participants |
| Active Locations | 120 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | September 28, 2026 (3 weeks ago) |
As of October 24, 2026: Clinical trial NCT07761117 is currently recruiting participants. This phase3 study for heart failure with preserved ejection fraction (hfpef) is actively seeking new participants at 120 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07761117 is actively recruiting participants as of October 24, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 120 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07761117 was last updated 3 weeks ago (September 28, 2026). HelloStudys verifies this status automatically.